Massachusetts Financial Services Co. MA Has $106.19 Million Stake in Revvity Inc. $RVTY

Massachusetts Financial Services Co. MA trimmed its position in Revvity Inc. (NYSE:RVTY) by 4.2% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,097,539 shares of the company’s stock after selling 48,241 shares during the quarter. Massachusetts Financial Services Co. MA owned 0.97% of Revvity worth $106,187,000 at the end of the most recent reporting period.

Other large investors have also modified their holdings of the company. AQR Capital Management LLC grew its position in Revvity by 5.2% in the first quarter. AQR Capital Management LLC now owns 8,449 shares of the company’s stock valued at $883,000 after acquiring an additional 420 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its position in Revvity by 6.7% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 11,776 shares of the company’s stock valued at $1,246,000 after acquiring an additional 744 shares during the period. Millennium Management LLC grew its position in Revvity by 102.0% in the first quarter. Millennium Management LLC now owns 69,401 shares of the company’s stock valued at $7,343,000 after acquiring an additional 35,048 shares during the period. Goldman Sachs Group Inc. grew its position in Revvity by 45.5% in the first quarter. Goldman Sachs Group Inc. now owns 607,104 shares of the company’s stock valued at $64,232,000 after acquiring an additional 189,871 shares during the period. Finally, Focus Partners Wealth grew its position in Revvity by 13.0% in the first quarter. Focus Partners Wealth now owns 7,028 shares of the company’s stock valued at $744,000 after acquiring an additional 811 shares during the period. 86.65% of the stock is currently owned by institutional investors and hedge funds.

Revvity Trading Up 3.1%

NYSE:RVTY opened at $92.54 on Tuesday. Revvity Inc. has a 1-year low of $81.36 and a 1-year high of $118.30. The business’s 50-day moving average price is $92.93 and its two-hundred day moving average price is $96.86. The company has a current ratio of 1.68, a quick ratio of 1.40 and a debt-to-equity ratio of 0.36. The firm has a market capitalization of $10.35 billion, a price-to-earnings ratio of 44.49, a PEG ratio of 1.91 and a beta of 1.13.

Revvity (NYSE:RVTY) last released its quarterly earnings results on Monday, February 2nd. The company reported $1.70 EPS for the quarter, topping analysts’ consensus estimates of $1.55 by $0.15. The company had revenue of $772.06 million for the quarter, compared to analyst estimates of $759.81 million. Revvity had a return on equity of 7.92% and a net margin of 8.45%.Revvity’s revenue was up 5.9% compared to the same quarter last year. During the same quarter last year, the firm posted $1.42 earnings per share. Revvity has set its FY 2026 guidance at 5.350-5.450 EPS. On average, equities analysts expect that Revvity Inc. will post 4.94 earnings per share for the current year.

Revvity Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, May 8th. Investors of record on Friday, April 17th will be issued a dividend of $0.07 per share. The ex-dividend date is Friday, April 17th. This represents a $0.28 dividend on an annualized basis and a dividend yield of 0.3%. Revvity’s dividend payout ratio (DPR) is presently 13.46%.

Analysts Set New Price Targets

A number of analysts have weighed in on the company. TD Cowen reiterated a “hold” rating on shares of Revvity in a research report on Tuesday, February 3rd. Wells Fargo & Company upped their price target on Revvity from $107.00 to $110.00 and gave the company an “equal weight” rating in a research report on Tuesday, February 3rd. Evercore increased their target price on Revvity from $112.00 to $118.00 and gave the stock an “outperform” rating in a report on Tuesday, February 3rd. Robert W. Baird set a $129.00 target price on Revvity in a report on Tuesday, February 3rd. Finally, Weiss Ratings cut Revvity from a “hold (c-)” rating to a “sell (d+)” rating in a report on Wednesday, March 18th. Five equities research analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus target price of $112.92.

Revvity Profile

Revvity, Inc is a global provider of technology-enabled solutions for the life sciences, diagnostics and applied markets. The company develops and supplies a range of products and services, including reagents and consumables, laboratory instruments, workflow automation, software analytics and technical support. Its portfolio supports applications in drug discovery, genomics, cell biology research, environmental and food safety testing, industrial quality control and clinical diagnostics.

Tracing its heritage to Perkin-Elmer, founded in 1937, Revvity began trading on the New York Stock Exchange under the ticker symbol RVTY in January 2024 following a corporate rebranding.